IMR Platform Expansion
Other Neurological Disorders (e.g., Parkinsonism)
ResearchActive
Key Facts
About MagQu
MagQu is a diagnostics company built on its patented ImmunoMagnetic Reduction (IMR) technology, which enables picoscale, highly sensitive detection of biomarkers in blood. Its core focus is on developing and commercializing assays for Alzheimer's disease (detecting Aβ-40, Aβ-42, and Tau proteins) and cancers like liver and colorectal cancer. The company is commercial-stage, with ISO and GMP certifications, TFDA approvals for its analyzers, and a growing international sales footprint across Asia, Europe, and the US.
View full company profile